These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 10403165)

  • 1. Trace lithium in mood disorders.
    Dafflon M; Décosterd LA; Biollaz J; Preisig M; Dufour H; Buclin T
    J Affect Disord; 1999 Jul; 54(1-2):199-203. PubMed ID: 10403165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of trace lithium in human erythrocytes by electrothermal atomic-absorption spectrometry with pyrocoated graphite tubes and integrated platform.
    Decosterd LA; Buclin T; Dafflon M; Leeman C; Bélaz N; Magnin JL; Biollaz J
    J Pharm Pharmacol; 1998 Jun; 50(6):693-701. PubMed ID: 9680083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lithium for maintenance treatment of mood disorders.
    Burgess S; Geddes J; Hawton K; Townsend E; Jamison K; Goodwin G
    Cochrane Database Syst Rev; 2001; (3):CD003013. PubMed ID: 11687035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tryptophan depletion in lithium-stabilized patients with affective disorder.
    Johnson L; El-Khoury A; Aberg-Wistedt A; Stain-Malmgren R; Mathé AA
    Int J Neuropsychopharmacol; 2001 Dec; 4(4):329-36. PubMed ID: 11806858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Guidelines for the prescription of mood stabilizers for adolescents: A literature review].
    Munch G; Godart N
    Encephale; 2017 Oct; 43(5):464-470. PubMed ID: 27871720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Predictors of prophylactic response to lithium].
    Rohayem J; Baylé JF; Richa S
    Encephale; 2008 Sep; 34(4):394-9. PubMed ID: 18922242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lithium ion transport and affective disorders within families of bipolar patients. Identification of a major gene locus.
    Dorus E; Cox NJ; Gibbons RD; Shaughnessy R; Pandey GN; Cloninger CR
    Arch Gen Psychiatry; 1983 May; 40(5):545-52. PubMed ID: 6838332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lithium-induced EEG changes in patients with affective disorders.
    Schulz C; Mavrogiorgou P; Schröter A; Hegerl U; Juckel G
    Neuropsychobiology; 2000; 42 Suppl 1():33-7. PubMed ID: 11093069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of CNS signal transduction pathways and gene expression by mood-stabilizing agents: therapeutic implications.
    Manji HK; Bebchuk JM; Moore GJ; Glitz D; Hasanat KA; Chen G
    J Clin Psychiatry; 1999; 60 Suppl 2():27-39; discussion 40-1, 113-6. PubMed ID: 10073385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mood stabilizers in the prevention of recurrent affective disorders: a meta-analysis.
    Davis JM; Janicak PG; Hogan DM
    Acta Psychiatr Scand; 1999 Dec; 100(6):406-17. PubMed ID: 10626918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RBC-choline: a biological marker of the outcome of lithium prophylaxis?
    Haag M; Granzow L; Greil W; Haag H
    Prog Neuropsychopharmacol Biol Psychiatry; 1987; 11(2-3):209-12. PubMed ID: 2888160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between prophylactic effect of lithium therapy and family history of affective disorders.
    Engström C; Aström M; Nordqvist-Karlsson B; Adolfsson R; Nylander PO
    Biol Psychiatry; 1997 Sep; 42(6):425-33. PubMed ID: 9285078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Search for a common mechanism of mood stabilizers.
    Harwood AJ; Agam G
    Biochem Pharmacol; 2003 Jul; 66(2):179-89. PubMed ID: 12826261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced plasma and CSF gamma-aminobutyric acid in affective illness: effect of lithium carbonate.
    Berrettini WH; Nurnberger JI; Hare TA; Simmons-Alling S; Gershon ES; Post RM
    Biol Psychiatry; 1983 Feb; 18(2):185-94. PubMed ID: 6403063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effectiveness of lithium in the prophylaxis of affective disorders].
    Ezquiaga E; García-López A; Nieves P; Rodríguez-Salvanés F
    Actas Esp Psiquiatr; 2000; 28(3):156-60. PubMed ID: 11000697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Introduction: the use of mood stabilizers in the treatment of psychiatric disorders.
    Bowden CL
    J Clin Psychiatry; 1999; 60 Suppl 5():3-4. PubMed ID: 10192401
    [No Abstract]   [Full Text] [Related]  

  • 17. Lithium in the long-term treatment of bipolar disorders.
    Kleindienst N; Greil W
    Eur Arch Psychiatry Clin Neurosci; 2003 Jun; 253(3):120-5. PubMed ID: 12904975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of mood-stabilizing drugs on cytokine levels in bipolar disorder: A systematic review.
    van den Ameele S; van Diermen L; Staels W; Coppens V; Dumont G; Sabbe B; Morrens M
    J Affect Disord; 2016 Oct; 203():364-373. PubMed ID: 27344047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder.
    Macritchie KA; Geddes JR; Scott J; Haslam DR; Goodwin GM
    Cochrane Database Syst Rev; 2001; (3):CD003196. PubMed ID: 11687047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammation-Related Changes in Mood Disorders and the Immunomodulatory Role of Lithium.
    Sakrajda K; Szczepankiewicz A
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33546417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.